Omega Announces Second Quarter 2013 Financial Results; Adjusted FFO of $0.62 Per Share for the Secon

Omega Announces Second Quarter 2013 Financial Results; Adjusted FFO of $0.62 Per Share for the Second Quarter

HUNT VALLEY, Md.--(BUSINESS WIRE)-- Omega Healthcare Investors, Inc. (NYS: OHI) (the "Company" or "Omega") today announced its results of operations for the three- and six-month period ended June 30, 2013. The Company also reported Funds From Operations ("FFO") available to common stockholders for the three-month period ended June 30, 2013 of $82.4 million or $0.70 per common share. The $82.4 million of FFO available to common stockholders for the second quarter of 2013 includes an $11.1 million gain related to the early extinguishment of debt, $1.5 million of non-cash stock-based compensation expense and a $65 thousand provision for uncollectible straight-line accounts receivable. The $11.1 million interest refinancing adjustment (gain) is related to the write-off of the remaining fair market value debt adjustment on 11 mortgage loans the Company paid off in May 2013. FFO is presented in accordance with the guidelines for the calculation and reporting of FFO issued by the National Association of Real Estate Investment Trusts ("NAREIT"). Normalized or Adjusted FFO was $0.62 per common share for the three-month period ended June 30, 2013. FFO and Adjusted FFO are non-GAAP financial measures. Normalized or Adjusted FFO is calculated as FFO available to common stockholders excluding the impact of certain non-cash items and certain items of revenue or expense, including, but not limited to: acquisitions, refinancing interest expenses, provisions for uncollectible accounts receivable and stock-based compensation expense. For more information regarding FFO and Adjusted FFO, see the "Second Quarter 2013 Results - Funds From Operations" section below.

GAAP NET INCOME

For the three-month period ended June 30, 2013, the Company reported net income available to common stockholders of $49.1 million, or $0.42 per diluted common share, on operating revenues of $102.5 million. This compares to net income available to common stockholders of $30.6 million, or $0.29 per diluted common share, on operating revenues of $83.8 million, for the same period in 2012.

For the six-month period ended June 30, 2013, the Company reported net income available to common stockholders of $87.2 million, or $0.76 per diluted common share, on operating revenues of $204.3 million. This compares to net income available to common stockholders of $56.7 million, or $0.54 per diluted common share, on operating revenues of $168.3 million, for the same period in 2012.

The year-to-date increase in net income was primarily due to: (i) additional rental income and mortgage interest income associated with approximately $510 million of new investments made since the second quarter of 2012 and (ii) an $11.1 million interest refinancing adjustment (gain) recorded in the second quarter of 2013. These increases to net income were partially offset by (i) increased expenses associated with new investments made throughout 2012 and 2013, including: (a) $9.8 million in increased depreciation expense and (b) $3.6 million in increased interest expense and (ii) $5.4 million in interest refinancing costs relating to 2012 refinancing activities.

SECOND QUARTER 2013 HIGHLIGHTS AND OTHER RECENT DEVELOPMENTS

• In July 2013, the Company increased its quarterly common stock dividend to $0.47 per share.

• In Q2 2013, the Company paid off $51 million of long-term debt.

• In Q2 2013, the Company completed $25 million of new investments.

• In Q2 2013, the Company completed $10 million of capital renovation projects.

• In April 2013, the Company increased its quarterly common stock dividend to $0.46 per share.

SECOND QUARTER 2013 RESULTS

Operating Revenues and Expenses - Operating revenues for the three-month period ended June 30, 2013 were $102.5 million. Operating expenses for the three-month period ended June 30, 2013 totaled $37.8 million and were comprised of $32.2 million of depreciation and amortization expense, $4.0 million of general and administrative expense, $1.5 million of stock-based compensation expense and a $65 thousand provision for uncollectible straight-line accounts receivable.

Other Income and Expense - Other income and expense for the three-month period ended June 30, 2013 was a net expense of $14.5 million, which was comprised of $25.0 million of interest expense and $0.7 million of amortized deferred financing costs. The Company also recorded an $11.1 million interest refinancing adjustment (gain) related to the write-off of the remaining fair market value debt adjustment on 11 mortgage loans that the Company paid off in May 2013.

Funds From Operations - For the three-month period ended June 30, 2013, reportable FFO available to common stockholders was $82.4 million, or $0.70 per common share on 117 million weighted-average common shares outstanding, compared to $55.8 million, or $0.53 per common share on 106 million weighted-average common shares outstanding, for the same period in 2012.

The $82.4 million of FFO for the three-month period ended June 30, 2013 includes the impact of the $11.1 million interest refinancing adjustment (gain), $1.5 million of stock-based compensation expense and the $65 thousand provision for uncollectible straight-line accounts receivable.

The $55.8 million of FFO for the three-month period ended June 30, 2012 includes the impact of the $1.7 million interest refinancing adjustment (gain), $1.5 million of stock-based compensation expense and $0.1 million of expense associated with recently completed acquisitions.

Adjusted FFO was $72.9 million, or $0.62 per common share, for the three months ended June 30, 2013, compared to $55.7 million, or $0.53 per common share, for the same period in 2012. The Company had 11.0 million additional weighted-average shares outstanding for the three months ended June 30, 2013 compared to the same period in 2012. For further information see "Funds From Operations" below.

FINANCING ACTIVITIES

$51 Million HUD Mortgage Payoffs - On May 31, 2013, the Company paid approximately $51 million to retire 11 mortgage loans guaranteed by the Department of Housing and Urban Development ("HUD"). The loans were assumed as part of the June 2010 purchase of 40 skilled nursing facilities ("SNFs") from affiliates of CapitalSource, Inc. and had a blended interest rate of 6.61% per annum with maturities between January 2036 and May 2040. The payoff resulted in an $11.1 million gain on the extinguishment of the debt due to the write-off of the remaining fair market value adjustment offset by a prepayment fee of $0.2 million.

Equity Shelf Program and Dividend Reinvestment and Common Stock Purchase Plan - During the six-month period ended June 30, 2013, the Company sold the following shares of its common stock under its Equity Shelf Programs and its Dividend Reinvestment and Common Stock Purchase Plan:

2013 PORTFOLIO AND RECENT DEVELOPMENTS

$25 Million Mezzanine Loan - On May 2, 2013, the Company invested $24.9 million in a mezzanine loan with a third party. The loan bears interest at 12% per annum and matures in December 2017.

$10 Million of Capital Renovation Projects in Q2 2013 - For the three-month period ending June 30, 2013, the Company invested approximately $10 million under its capital renovation programs.

Facility Sales - For the three-month period ended June 30, 2013, the Company sold one facility in Texas for total cash proceeds of $2.2 million, resulting in a loss on sale of $1.2 million.

DIVIDENDS

On July 17, 2013,the Company's Board of Directors announced a common stock dividend of $0.47 per share, increasing the quarterly common dividend by $0.01 per share over the prior quarter, to be paid August 15, 2013 to common stockholders of record on July 31, 2013.

2013 ADJUSTED FFO AND ADJUSTED FAD GUIDANCE

The Company revised its 2013 Adjusted FFO available to common stockholders to be between $2.48 and $2.51 per diluted share and its 2013 Adjusted Funds Available For Distribution ("FAD") available to common stockholders to be between $2.23 and $2.26 per diluted share.

The Company's Adjusted FFO and Adjusted FAD guidance for 2013 includes approximately $200 million of new investments (including capital renovation projects); however, it excludes the impact of gains and losses from the sale of assets, additional divestitures, certain revenue and expense items, interest refinancing expense, capital transactions and stock-based compensation expense. A reconciliation of the Adjusted FFO and FAD guidance to the Company's projected GAAP earnings is provided on schedules attached to this press release. The Company may, from time to time, update its publicly announced Adjusted FFO and FAD guidance, but it is not obligated to do so.

The Company's Adjusted FFO and FAD guidance is based on a number of assumptions, which are subject to change and many of which are outside the Company's control. If actual results vary from these assumptions, the Company's expectations may change. Without limiting the generality of the foregoing, the timing and completion of acquisitions, divestitures, capital and financing transactions, and variations in restricted stock amortization expense may cause actual results to vary materially from our current expectations. There can be no assurance that the Company will achieve its projected results.

CONFERENCE CALL

The Company will be conducting a conference call on Thursday, August 1, 2013, at 10 a.m. Eastern to review the Company's 2013 second quarter results and current developments. Analysts and investors within the United States interested in participating are invited to call (888) 317-6016. The Canadian toll-free dial-in number is (855) 669-9657. All other international participants can use the dial-in number (412) 317-6016. Ask the operator to be connected to the "Omega Healthcare's Second Quarter 2013 Earnings Call."

To listen to the conference call via webcast, log on to www.omegahealthcare.com and click the "earnings call" icon on the Company's home page. Webcast replays of the call will be available on the Company's website for two weeks following the call.

The Company is a real estate investment trust investing in and providing financing to the long-term care industry. At June 30, 2013, the Company owned or held mortgages on 477 skilled nursing facilities, assisted living facilities and other specialty hospitals with approximately 55,075 licensed beds (52,890 available beds) located in 33 states and operated by 47 third-party healthcare operating companies.

This announcement includes forward-looking statements, including without limitation the information under the heading "2013 Adjusted FFO and Adjusted FAD Guidance Confirmed."Actual results may differ materially from those reflected in such forward-looking statements as a result of a variety of factors, including, among other things: (i) uncertainties relating to the business operations of the operators of the Company's properties, including those relating to reimbursement by third-party payors, regulatory matters and occupancy levels; (ii) regulatory and other changes in the healthcare sector; (iii) changes in the financial position of the Company's operators; (iv) the ability of any of the Company's operators in bankruptcy to reject unexpired lease obligations, modify the terms of the Company's mortgages and impede the ability of the Company to collect unpaid rent or interest during the pendency of a bankruptcy proceeding and retain security deposits for the debtor's obligations; (v) the availability and cost of capital; (vi) changes in the Company's credit ratings and the ratings of its debt securities; (vii) competition in the financing of healthcare facilities; (viii) the Company's ability to maintain its status as a real estate investment trust; (ix) the Company's ability to manage, re-leaseor sell any owned and operated facilities; (x) the Company's ability to sell closed or foreclosed assets on a timely basis and on terms that allow the Company to realize the carrying value of these assets; (xi) the effect of economic and market conditions generally, and particularly in the healthcare industry; and (xii) other factors identified in the Company's filings with the Securities and Exchange Commission. Statements regarding future events and developments and the Company's future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements.The Company undertakes no obligation to update any forward-looking statements contained in this announcement.